Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) reached a new 52-week high during trading on Tuesday after UBS Group raised their price target on the stock from $150.00 to $160.00. UBS Group currently has a buy rating on the stock. Cardinal Health traded as high as $139.97 and last traded at $139.79, with a volume of 499827 shares changing hands. The stock had previously closed at $138.24.
A number of other equities analysts have also recently weighed in on the company. Bank of America boosted their price target on Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a report on Friday, April 11th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a report on Tuesday, January 7th. Mizuho upped their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an “outperform” rating in a research note on Monday, March 31st. Finally, Morgan Stanley lifted their target price on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research note on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $142.36.
View Our Latest Analysis on Cardinal Health
Institutional Investors Weigh In On Cardinal Health
Cardinal Health Price Performance
The business’s 50-day moving average price is $131.30 and its two-hundred day moving average price is $124.38. The firm has a market cap of $33.77 billion, a price-to-earnings ratio of 26.08, a P/E/G ratio of 1.49 and a beta of 0.61.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date of this dividend was Tuesday, April 1st. Cardinal Health’s dividend payout ratio is presently 37.69%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- What is the S&P 500 and How It is Distinct from Other Indexes
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- How to trade penny stocks: A step-by-step guide
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- Which Wall Street Analysts are the Most Accurate?
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.